Donglu Zhang, Ph D, is a Principal Scientist in Pharmaceutical Candidate Optimization at Bristol-Myers Squibb in Princeton, New Jersey. He has published seventy peer-reviewed articles, codiscovered the Mass Defect Filtering technique, and coedited two books.
Sekhar Surapaneni, Ph D, is Director, DMPK, at Celgene Corporation in New Jersey. He has published extensively in peer-reviewed journals and is a member of ISSX and ACS.
2 Ebooks por Sekhar Surapaneni
Sekhar Surapaneni & Donglu Zhang: ADME-Enabling Technologies in Drug Design and Development
A comprehensive guide to cutting-edge tools in ADME research
The last decade has seen tremendous progress in the development of analytical techniques such as mass spectrometry and molecular biology …
PDF
Inglês
€169.99
Sekhar Surapaneni & Donglu Zhang: ADME-Enabling Technologies in Drug Design and Development
A comprehensive guide to cutting-edge tools in ADME research
The last decade has seen tremendous progress in the development of analytical techniques such as mass spectrometry and molecular biology …
EPUB
Inglês
€169.99
